Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVXW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Enovix Corporation's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Enovix Corporation's regulatory disclosures and financial reporting.
Arthi Chakravarthy, the Chief Legal Officer of Enovix Corporation, reported a transaction dated 08/08/2025 reflecting the withholding of 934 shares to satisfy tax-withholding obligations upon the vesting of restricted stock units (RSUs). The shares were withheld at an effective price of $10.78. After this withholding, the reporting person beneficially owns 428,183 shares directly, which includes 337,993 shares issuable upon settlement of RSUs that remain part of her beneficial stake. The filing shows no derivative transactions reported and is signed on 08/12/2025.
Raj Talluri, President and CEO and director of Enovix Corporation, reported a routine equity withholding related to RSU vesting on 08/08/2025. The filing shows 4,292 shares of the issuer's common stock were withheld to satisfy tax withholding obligations at a reported price of $10.78 per share in connection with the vesting of restricted stock units.
After the withholding, the reporting person is recorded as beneficially owning 2,400,818 shares (direct). That total explicitly includes 1,887,185 shares issuable upon settlement of outstanding RSUs granted to the reporting person.
Kristina Truong, Enovix's Chief Accounting Officer, reported a non-derivative equity transaction on 08/08/2025 in which 252 shares of common stock were withheld to satisfy tax withholding upon the vesting of restricted stock units (each RSU converts to one share). The withheld shares carry a reported per-share price of $10.78. The filing shows 206,860 shares beneficially owned following the transaction, which explicitly includes 173,141 shares issuable upon settlement of RSUs. This disclosure reflects a routine equity-compensation settlement and tax withholding rather than an open-market sale.
Ajay Marathe, listed as Chief Operating Officer, reported an RSU vesting-related transaction dated 08/08/2025. The issuer withheld 1,490 shares to satisfy tax withholding on vested restricted stock units. After the reported transaction Marathe is shown as beneficially owning 1,164,353 shares, which includes 824,667 shares issuable upon RSU settlement. The Form 4 was signed by an attorney-in-fact on 08/12/2025. No derivative transactions were reported.
Thurman J. Rodgers, a director and reported >10% owner of Enovix Corporation (ENVX), reported exercising 220,114 publicly-traded warrants into common stock at an $8.75 exercise price, with the resulting shares held by a charitable trust for which he is trustee. The filing shows 1,120,114 shares beneficially owned following the transaction in that trust and an additional 20,858,407 shares held indirectly by a separate revocable trust. The revocable trust also holds 2,914,466 warrants. The report notes 22,543 restricted stock units outstanding for the reporting person. The warrants were distributed by the issuer at no cost and expire on October 1, 2026.
Thurman J. Rodgers, a director and 10% owner of Enovix Corporation, reported on Form 4 that publicly distributed warrants were exercised on 08/08/2025, resulting in the acquisition of 57,142 shares at an exercise price of $8.75 per share. The filing states the warrants were distributed by the issuer on July 21, 2025 and will expire on October 1, 2026, subject to possible acceleration under the Warrant Agreement. Rodgers reports beneficial ownership through the Rodgers Massey Revocable Living Trust and the Rodgers Family Freedom and Free Markets Charitable Trust, for which he is trustee with voting and dispositive power, bringing reported beneficial ownership to 20,858,407 shares. The filing also discloses 22,543 restricted stock units that are contingent rights to common stock.
Raj Talluri K, President, CEO and a director of Enovix Corporation, reported on Form 4 that 22,857 shares of common stock were issued to him on 08/07/2025 upon the exercise of publicly-traded warrants. The warrants were distributed by the company on July 21, 2025 and carried an exercise price of $8.75 per share. After the transaction, the filing shows the reporting person beneficially owned 2,405,110 shares, which includes 1,895,306 shares issuable upon settlement of restricted stock units (RSUs). The Form 4 was signed by an attorney-in-fact on 08/11/2025.
Form 4 summary: Reporting person Bernard Gutmann (Director) reported a transaction for Enovix Corp (ticker shown as ENVX) dated 08/06/2025.
- Transaction: Exercise of publicly-traded warrants resulting in 5,096 shares issued at an exercise price of $8.75 per share.
- Post-transaction beneficial ownership: 69,959 shares (this total includes 29,190 RSUs issuable upon settlement).
- Filing details: Form filed by one reporting person; form signed by Attorney-in-Fact Arthi Chakravarthy on 08/07/2025.
FAQ
What is the current stock price of Enovix Corporation (ENVXW)?
